Beichen Xie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Beichen Xie has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Andreas Müller
Molecular Diabetology, University Hospital and Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany
1 shared publication - Ceren Incedal Nilsson
Department of Medical Cell Biology, Uppsala University, BMC Box 571, 75123, Uppsala, Sweden
1 shared publication - Chao Tang
Center for Quantitative Biology, Peking University, Beijing 100871, China; Peking-Tsinghua Center for Life Sciences, Peking University, Beijing 100871, China
1 shared publication - Gonzalo Sanchez
Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden
1 shared publication Huixia Ren
Center for Quantitative Biology, Peking University, 100871, Beijing, China
1 shared publication- Jing Ling
Peking-Tsinghua Center for Life Science, Academy for Advanced Interdisciplinary Studies, Peking University
1 shared publication
Latest Publications
- Open Access
- 8 August 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (32) , eads1807
Positive-going hybrid indicators for voltage imaging in excitable cells and tissues
Membrane potential dynamics are crucial to the physiology of electrically excitable cells, such as neurons, cardiomyocytes, and pancreatic islet cells. Fluorescence voltage indicators have enabled the visualization of electrical activities at the single-cell level across large cell populations. However, most existing indicators have a negative fluorescence-voltage response, resulting in a high background signal when cells are at their resting state. To reduce background interference during voltage imaging, we developed a positive-going hybrid voltage indicator (HVI + ), which has lower intensity at the resting state and becomes brighter upon membrane depolarization. HVI + -Cy3b exhibits a remarkable voltage sensitivity of 55% Δ F / F 0 per 100 mV, enabling accurate reporting of action potential waveforms in beating cardiomyocytes and neurons. In addition, by combining HVI + -Cy3b with HVI-Cy3b, we demonstrate the capability to simultaneously assess the effects of glucose on the spike activities of two cell types in pancreatic islets.
- 8 August 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (32) , eads1807
Open AccessPositive-going hybrid indicators for voltage imaging in excitable cells and tissues
Membrane potential dynamics are crucial to the physiology of electrically excitable cells, such as neurons, cardiomyocytes, and pancreatic islet cells. Fluorescence voltage indicators have enabled the visualization of electrical activities at the single-cell level across large cell populations. However, most existing indicators have a negative fluorescence-voltage response, resulting in a high background signal when cells are at their resting state. To reduce background interference during voltage imaging, we developed a positive-going hybrid voltage indicator (HVI + ), which has lower intensity at the resting state and becomes brighter upon membrane depolarization. HVI + -Cy3b exhibits a remarkable voltage sensitivity of 55% Δ F / F 0 per 100 mV, enabling accurate reporting of action potential waveforms in beating cardiomyocytes and neurons. In addition, by combining HVI + -Cy3b with HVI-Cy3b, we demonstrate the capability to simultaneously assess the effects of glucose on the spike activities of two cell types in pancreatic islets.
- Open Access
- 12 February 2025
- Published by Springer Nature in The EMBO Journal
- Vol. 44 (6) , 1663-1691
Somatostatin triggers local cAMP and Ca2+ signaling in primary cilia to modulate pancreatic β-cell function
Somatostatin, released from δ-cells within pancreatic islets of Langerhans, is one of the most important negative regulators of islet hormone secretion. We find that islet δ-cells are positioned near, and release somatostatin onto, primary cilia of the other islet cell types, including insulin-secreting β-cells. Somatostatin activates ciliary somatostatin receptors, resulting in rapid lowering of the ciliary cAMP concentration which in turn promotes more sustained nuclear translocation of the cilia-dependent transcription factor GLI2 through a mechanism that operates in parallel with the canonical Hedgehog pathway and depends on ciliary Ca 2+ signaling. We also find that primary cilia length is reduced in islets from human donors with type-2 diabetes, which is associated with a reduction in interactions between δ-cells and cilia. Our findings show that islet cell primary cilia constitute an important target of somatostatin action, which endows somatostatin with the ability to regulate islet cell function beyond acute suppression of hormone release.
- 12 February 2025
- Published by Springer Nature in The EMBO Journal
- Vol. 44 (6) , 1663-1691
Open AccessSomatostatin triggers local cAMP and Ca2+ signaling in primary cilia to modulate pancreatic β-cell function
Somatostatin, released from δ-cells within pancreatic islets of Langerhans, is one of the most important negative regulators of islet hormone secretion. We find that islet δ-cells are positioned near, and release somatostatin onto, primary cilia of the other islet cell types, including insulin-secreting β-cells. Somatostatin activates ciliary somatostatin receptors, resulting in rapid lowering of the ciliary cAMP concentration which in turn promotes more sustained nuclear translocation of the cilia-dependent transcription factor GLI2 through a mechanism that operates in parallel with the canonical Hedgehog pathway and depends on ciliary Ca 2+ signaling. We also find that primary cilia length is reduced in islets from human donors with type-2 diabetes, which is associated with a reduction in interactions between δ-cells and cilia. Our findings show that islet cell primary cilia constitute an important target of somatostatin action, which endows somatostatin with the ability to regulate islet cell function beyond acute suppression of hormone release.